Top

Reactions Weekly

Published in:

01-10-2023 | Adalimumab | Case report

Adalimumab

Paroxysmal ventricular tachycardia leading to angina: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Hernandez-Duran MD, et al. RESULTADOS DE LA TRANSICION DE ADALIMUMAB DE REFERENCIA AL BIOSIMILAR SB5 EN PACIENTES CON ENFERMEDAD DE CROHN EN LA PRACTICA CLINICA: SUBANALISIS DE LOS PACIENTES ESPANOLES DEL ESTUDIO PROPER TRAS 48 SEMANAS DE SEGUIMIENTO. Gastroenterologia y Hepatologia 46 (Suppl. 3): S118 abstr. 86, Jan 2023. Available from: URL: http://doi.org/10.1016/S0210-5705%2823%2900218-2 [Spanish abstract; summarised from a translation]

Title: Adalimumab
Paroxysmal ventricular tachycardia leading to angina: case report
Publication date: 01-10-2023
Publisher: Springer International Publishing
Keywords: Adalimumab
Ventricular Tachycardia
Crohn's Disease
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-48210-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Adalimumab

Paroxysmal ventricular tachycardia leading to angina: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Multiple drugs

Multiple drugs

Ceftriaxone

Tozinameran

Fentanyl abuse

Venetoclax